Mr Bruce John Anderson, MD | |
2724 Isle Royale Ct, Burnsville, MN 55337-3424 | |
(952) 707-6781 | |
Not Available |
Full Name | Mr Bruce John Anderson |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 38 Years |
Location | 2724 Isle Royale Ct, Burnsville, Minnesota |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1497783955 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 32095 (Minnesota) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Regents Of The University Of Minnesota | 7416856059 | 61 |
News Archive
Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, is pleased to report that it is actively enrolling patients in a placebo-controlled, randomized double-blinded Phase IIa study evaluating the safety and efficacy for JVS-100 in patients with Rutherford Class 4 or 5 critical limb ischemia.
New ways to study the impact of HIV/AIDS on rural African families is showing that conventional wisdom isn't necessarily wise, and pointing to better ways to help those struggling in the wake of death.
Decreased diversity in the microbial community found in the human gut is associated with colorectal cancer, according to a new study published December 6 in the Journal of the National Cancer Institute.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 9 days ago
Entity Name | Regents Of The University Of Minnesota |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1114019858 PECOS PAC ID: 7416856059 Enrollment ID: O20040102000679 |
News Archive
Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, is pleased to report that it is actively enrolling patients in a placebo-controlled, randomized double-blinded Phase IIa study evaluating the safety and efficacy for JVS-100 in patients with Rutherford Class 4 or 5 critical limb ischemia.
New ways to study the impact of HIV/AIDS on rural African families is showing that conventional wisdom isn't necessarily wise, and pointing to better ways to help those struggling in the wake of death.
Decreased diversity in the microbial community found in the human gut is associated with colorectal cancer, according to a new study published December 6 in the Journal of the National Cancer Institute.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Bruce John Anderson, MD 2724 Isle Royale Ct, Burnsville, MN 55337-3424 Ph: (952) 707-6781 | Mr Bruce John Anderson, MD 2724 Isle Royale Ct, Burnsville, MN 55337-3424 Ph: (952) 707-6781 |
News Archive
Juventas Therapeutics, a privately-held, clinical-stage company developing novel regenerative therapies for treatment of cardiovascular disease, is pleased to report that it is actively enrolling patients in a placebo-controlled, randomized double-blinded Phase IIa study evaluating the safety and efficacy for JVS-100 in patients with Rutherford Class 4 or 5 critical limb ischemia.
New ways to study the impact of HIV/AIDS on rural African families is showing that conventional wisdom isn't necessarily wise, and pointing to better ways to help those struggling in the wake of death.
Decreased diversity in the microbial community found in the human gut is associated with colorectal cancer, according to a new study published December 6 in the Journal of the National Cancer Institute.
Raptor Pharmaceutical Corp.,provides updates on timelines related to its clinical programs including the pivotal Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate ("DR Cysteamine") in patients with nephropathic cystinosis ("cystinosis").
› Verified 9 days ago
Dr. Geeta L Balkissoon, MB BS Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14000 Fairview Dr, Burnsville, MN 55337 Phone: 952-993-8700 | |
David Gray, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14000 Nicollet Ave Ste 100, Burnsville, MN 55337 Phone: 952-428-0200 | |
Dr. Albert Yeo, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14101 Fairview Dr Ste 300, Burnsville, MN 55337 Phone: 952-892-2650 | |
Michael C Magnuson, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 625 E Nicollet Blvd, Suite 100, Burnsville, MN 55337 Phone: 952-435-0303 Fax: 952-892-5166 | |
Venancio T Jo, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14000 Nicollet Ave Ste 100, Burnsville, MN 55337 Phone: 952-428-0200 | |
Tim A Meyer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 14000 Nicollet Ave, Burnsville Medical Center, Burnsville, MN 55337 Phone: 952-985-8255 Fax: 952-985-8299 | |
Shabana Siddiqui, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14000 Fairview Dr, Park Nicollet Clinic - Burnsville, Burnsville, MN 55337 Phone: 952-993-8700 Fax: 952-993-8715 |